title: How should Helicobacter pylori negative patients be managed?
abstract: Dyspepsia is a digestive syndrome distinct from (although frequently overlapping with) gastro-oesophageal reflux disease (GORD) and irritable bowel syndrome (IBS), which is characterised by various combinations of painful and non-painful symptoms arising from the epigastrium. Dyspepsia can be secondary to a variety of diseases, but in most instances it is idiopathic. Helicobacter pylori infection is responsible for the majority of peptic ulcers and of other diseases potentially associated with dyspepsia. Nevertheless, a causal role for H pylori infection in symptom occurrence has not been established. Experimental data indicate that H pylori eradication does not improve symptoms in the majority of dyspeptic patients. It has been proposed recently that H pylori negative patients should be managed according to their clinical presentation. Some reports suggest that taking into consideration the most relevant or "predominant" symptom may help to identify distinct subgroups among dyspeptic patients with different underlying pathophysiological abnormalities and different responses to treatment. Well designed and conducted prospective studies are needed to verify whether treatment of H pylori negative dyspeptic patients based on the predominant symptom actually is a cost effective approach.
authors.affiliation: Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Stanghellini
authors.forename: C
authors.initials: C
authors.lastname: Tosetti
authors.forename: R
authors.initials: R
authors.lastname: De Giorgio
authors.forename: G
authors.initials: G
authors.lastname: Barbara
authors.forename: B
authors.initials: B
authors.lastname: Salvioli
authors.forename: R
authors.initials: R
authors.lastname: Corinaldesi
mesh_terms: D004415:Dyspepsia / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans